1. Dyakonova O, Reiter S. Scientists in Russia have tested the Covid vaccine on themselves. Pharmaceutical companies considered it a violation. BBC 2020. https://www.bbc.com/russian/news-52772808
2. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
3. Bucci E. Note of concern. 2020. https://cattiviscienziati.com/2020/09/07/note-of-concern/
4. Gamaleya Center. The first interim data analysis of the Sputnik V vaccine against covid-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy. 2020. https://sputnikvaccine.com/newsroom/pressreleases/the-first-interim-data-analysis-of-the-sputnik-v-vaccine-against-covid-19-phase-iii-clinical-trials-/
5. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia